Legal & General Group
HCAT icon

Legal & General Group’s Health Catalyst HCAT Stock Holding History

Legal & General Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.8K Hold
6,140
– – ﹤0.01% 3234
2025
Q4 		$14.7K Hold
6,140
– – ﹤0.01% 3137
2025
Q3 		$17.5K Hold
6,140
– – ﹤0.01% 3093
2025
Q2 		$23.1K Buy
6,140
+527
+9% +$2.07K ﹤0.01% 2949
2025
Q1 		$25.4K Sell
5,613
-78,607
-93% -$416K ﹤0.01% 2859
2024
Q4 		$595K Sell
84,220
-6,327
-7% -$50.4K ﹤0.01% 2396
2024
Q3 		$737K Sell
90,547
-14,658
-14% -$106K ﹤0.01% 2339
2024
Q2 		$672K Sell
105,205
-30,075
-22% -$193K ﹤0.01% 2324
2024
Q1 		$1.02M Sell
135,280
-4,147
-3% -$37.9K ﹤0.01% 2183
2023
Q4 		$1.29M Sell
139,427
-48,995
-26% -$400K ﹤0.01% 2112
2023
Q3 		$1.91M Buy
188,422
+4,324
+2% +$51.6K ﹤0.01% 1918
2023
Q2 		$2.3M Buy
184,098
+35,508
+24% +$423K ﹤0.01% 1858
2023
Q1 		$1.73M Sell
148,590
-42,057
-22% -$536K ﹤0.01% 1942
2022
Q4 		$2.03M Buy
190,647
+15,951
+9% +$154K ﹤0.01% 1881
2022
Q3 		$1.69M Buy
174,696
+22,936
+15% +$304K ﹤0.01% 1948
2022
Q2 		$2.2M Buy
151,760
+53,132
+54% +$906K ﹤0.01% 1844
2022
Q1 		$2.58M Buy
98,628
+14,563
+17% +$413K ﹤0.01% 1868
2021
Q4 		$3.33M Buy
84,065
+11,581
+16% +$528K ﹤0.01% 1797
2021
Q3 		$3.63M Buy
72,484
+12,810
+21% +$699K ﹤0.01% 1721
2021
Q2 		$3.31M Sell
59,674
-7,052
-11% -$376K ﹤0.01% 1741
2021
Q1 		$3.12M Buy
66,726
+27,441
+70% +$1.33M ﹤0.01% 1791
2020
Q4 		$1.71M Buy
39,285
+13,228
+51% +$488K ﹤0.01% 1948
2020
Q3 		$954K Buy
26,057
+20,058
+334% +$681K ﹤0.01% 2042
2020
Q2 		$175K Buy
5,999
+2,349
+64% +$64.9K ﹤0.01% 2383
2020
Q1 		$96K Buy
3,650
+1,366
+60% +$41.7K ﹤0.01% 2423
2019
Q4 		$79K Buy
2,284
+926
+68% +$30.7K ﹤0.01% 2667
2019
Q3 		$43K Buy
+1,358
New +$53.5K ﹤0.01% 2799

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's HCAT Position: Q1 2026 in Review

Legal & General Group held its Health Catalyst (HCAT) position steady in Q1 2026 at 6,140 shares worth $7.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3234.

Legal & General Group first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $3.63M in Q3 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Legal & General Group held 6,140 shares of Health Catalyst worth $7.8K as of Q1 2026.
  • Legal & General Group left its Health Catalyst share count unchanged in Q1 2026.
  • Health Catalyst made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3234 holding.
  • Legal & General Group first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Legal & General Group's Health Catalyst position peaked at $3.63M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.